Does OSIMERTINIB Cause Dermatitis exfoliative? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Dermatitis exfoliative have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.0% of all adverse event reports for OSIMERTINIB.
6
Reports of Dermatitis exfoliative with OSIMERTINIB
0.0%
of all OSIMERTINIB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Dermatitis exfoliative From OSIMERTINIB?
Of the 6 reports, 3 (50.0%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Dermatitis exfoliative Listed in the Official Label?
Yes, Dermatitis exfoliative is listed as a known adverse reaction in the official FDA drug label for OSIMERTINIB.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Dermatitis exfoliative?
CIPROFLOXACIN (91)
ALLOPURINOL (86)
SULFAMETHOXAZOLE\TRIMETHOPRIM (75)
CLOPIDOGREL BISULFATE (73)
FUROSEMIDE (73)
ATORVASTATIN (71)
AMLODIPINE (70)
ACETAMINOPHEN (66)
VANCOMYCIN (66)
SIMVASTATIN (64)
Which OSIMERTINIB Alternatives Have Lower Dermatitis exfoliative Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN